©The Author(s) 2025.
World J Gastrointest Oncol. Sep 15, 2025; 17(9): 109055
Published online Sep 15, 2025. doi: 10.4251/wjgo.v17.i9.109055
Published online Sep 15, 2025. doi: 10.4251/wjgo.v17.i9.109055
Figure 4 High expression of pancreatic adenocarcinoma upregulated factor protein in pancreatic cancer patients is associated with reduced overall survival.
A: Pancreatic adenocarcinoma upregulated factor (PAUF) protein expression was categorized into PAUF-low and PAUF-high based on immunohistochemistry staining intensity and the proportion of stained tumor cells; B: Overall survival of patients with PAUF-low and PAUF-high was analyzed using Kaplan-Meier curves in patients with pancreatic cancer. PAUF: Pancreatic adenocarcinoma upregulated factor. aP < 0.05 vs pancreatic adenocarcinoma upregulated factor-low.
- Citation: Kim JH, Na HY, Jung K, Jang D, Youn Y, Kim DH, Han HD, Hwang JH. Quantitative immunohistochemistry analysis of pancreatic adenocarcinoma upregulated factor expression in pancreatic cancer and its prognostic significance. World J Gastrointest Oncol 2025; 17(9): 109055
- URL: https://www.wjgnet.com/1948-5204/full/v17/i9/109055.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i9.109055